Stem cell therapies in patients with single ventricle physiology

scientific article published on April 2014

Stem cell therapies in patients with single ventricle physiology is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.14797/MDCJ-10-2-77
P932PMC publication ID4117324
P698PubMed publication ID25114758

P2093author name stringHidemasa Oh
Shunji Sano
Suguru Tarui
P2860cites workIntracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trialQ29620043
RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trialQ29620044
Adult cardiac stem cells are multipotent and support myocardial regenerationQ29620122
Quantification of Diffuse Myocardial Fibrosis and Its Association With Myocardial Dysfunction in Congenital Heart DiseaseQ34624729
Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operationQ34702433
Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.Q35050037
Myocardial perfusion defects and associated systemic ventricular dysfunction in congenitally corrected transposition of the great arteriesQ35369247
Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cellsQ35799278
Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarctionQ36349782
A strong regenerative ability of cardiac stem cells derived from neonatal heartsQ36709832
Predictors of survival after single-ventricle palliation: the impact of right ventricular dominance.Q37996136
Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysisQ38021450
Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome.Q38511389
Five- to fifteen-year follow-up after Fontan operationQ38514255
Ultrastructure of crista supraventricularis muscle in patients with congenital heart diseases associated with right ventricular outflow tract obstructionQ39726707
Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathyQ39864941
Follow-up of the patients after stem cell transplantation for pediatric dilated cardiomyopathyQ42435066
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarctionQ42644713
Survival and clinical course at Fontan after stage one palliation with either a modified Blalock-Taussig shunt or a right ventricle to pulmonary artery conduitQ43704213
Intracoronary bone marrow cell application for terminal heart failure in childrenQ44576825
Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.Q48414650
Clinical profiles of adult patients with single ventricular physiologyQ48501311
Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration.Q50683671
Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training.Q54444779
Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart.Q54472692
Hypoplastic left heart syndromeQ56519809
A regenerative strategy for heart failure in hypoplastic left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cellsQ58816143
Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathyQ58816169
Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-upQ73069787
Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signalingQ79409654
Factors influencing early and late outcome following the Fontan procedure in the current era. The 'Two Commandments'?Q79607720
Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgeryQ80175472
Isolation and expansion of adult cardiac stem cells from human and murine heartQ80837204
Noncultured cell transplantation in an ovine model of right ventricular preparationQ81708831
Intramyocardial administration of autologous bone marrow mononuclear cells in a critically ill child with dilated cardiomyopathyQ82065946
Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarctionQ82750318
The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart diseaseQ84160135
Peripheric stem cell transplantation in children with dilated cardiomyopathy: preliminary report of first two casesQ84225516
Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experienceQ84570135
Single right ventricles have impaired systolic and diastolic function compared to those of left ventricular morphologyQ84970618
P433issue2
P304page(s)77-81
P577publication date2014-04-01
P1433published inMethodist DeBakey cardiovascular journalQ26841947
P1476titleStem cell therapies in patients with single ventricle physiology
P478volume10

Reverse relations

cites work (P2860)
Q26799556Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease
Q37670955Clinical cardiac regenerative studies in children
Q34478846Hypoplastic left heart syndrome - unresolved issues
Q39036971Managing heart failure in adults with congenital heart disease
Q58562094Recent advances and challenges on application of tissue engineering for treatment of congenital heart disease
Q26801514Stem cell therapy and tissue engineering for correction of congenital heart disease
Q26786034Stem cell therapy for CHD: towards translation
Q42587066Stem cells on a new stage: Treatment of hypoplastic left heart syndrome
Q42583515The emergence of stem cell therapy for patients with congenital heart disease

Search more.